These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 38401871)

  • 21. Novel Methods for Intranasal Administration Under Inhalation Anesthesia to Evaluate Nose-to-Brain Drug Delivery.
    Kanazawa T; Fukuda M; Suzuki N; Suzuki T
    J Vis Exp; 2018 Nov; (141):. PubMed ID: 30507914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intranasal drug delivery: opportunities and toxicologic challenges during drug development.
    Keller LA; Merkel O; Popp A
    Drug Deliv Transl Res; 2022 Apr; 12(4):735-757. PubMed ID: 33491126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physicochemical and physiological considerations for efficient nose-to-brain targeting.
    Bahadur S; Pathak K
    Expert Opin Drug Deliv; 2012 Jan; 9(1):19-31. PubMed ID: 22171740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insights into direct nose to brain delivery: current status and future perspective.
    Mittal D; Ali A; Md S; Baboota S; Sahni JK; Ali J
    Drug Deliv; 2014 Mar; 21(2):75-86. PubMed ID: 24102636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nose to brain transport pathways an overview: potential of nanostructured lipid carriers in nose to brain targeting.
    Selvaraj K; Gowthamarajan K; Karri VVSR
    Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):2088-2095. PubMed ID: 29282995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent Advances in Intranasal Administration for Brain-Targeting Delivery: A Comprehensive Review of Lipid-Based Nanoparticles and Stimuli-Responsive Gel Formulations.
    Koo J; Lim C; Oh KT
    Int J Nanomedicine; 2024; 19():1767-1807. PubMed ID: 38414526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood-brain barrier: an excellent platform for brain targeting.
    Pardeshi CV; Belgamwar VS
    Expert Opin Drug Deliv; 2013 Jul; 10(7):957-72. PubMed ID: 23586809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nose-to-brain drug delivery by nanoparticles in the treatment of neurological disorders.
    Ong WY; Shalini SM; Costantino L
    Curr Med Chem; 2014; 21(37):4247-56. PubMed ID: 25039773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nasal Drug Delivery of Anticancer Drugs for the Treatment of Glioblastoma: Preclinical and Clinical Trials.
    Bruinsmann FA; Richter Vaz G; de Cristo Soares Alves A; Aguirre T; Raffin Pohlmann A; Stanisçuaski Guterres S; Sonvico F
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31779126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs.
    Agrawal M; Saraf S; Saraf S; Antimisiaris SG; Chougule MB; Shoyele SA; Alexander A
    J Control Release; 2018 Jul; 281():139-177. PubMed ID: 29772289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Research progress on traditional Chinese medicine in preventing and treating cerebral ischemia injury based on "nose-brain" pathway].
    Wei ZZ; Fang XY; Fan SK; Peng MF; Bai M; Miao MS
    Zhongguo Zhong Yao Za Zhi; 2019 Nov; 44(22):4800-4805. PubMed ID: 31872585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nose-to-Brain Delivery.
    Wang Z; Xiong G; Tsang WC; Schätzlein AG; Uchegbu IF
    J Pharmacol Exp Ther; 2019 Sep; 370(3):593-601. PubMed ID: 31126978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. From nose to brain: understanding transport capacity and transport rate of drugs.
    Wu H; Hu K; Jiang X
    Expert Opin Drug Deliv; 2008 Oct; 5(10):1159-68. PubMed ID: 18817519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nanoemulsion-based intranasal drug delivery system of saquinavir mesylate for brain targeting.
    Mahajan HS; Mahajan MS; Nerkar PP; Agrawal A
    Drug Deliv; 2014 Mar; 21(2):148-54. PubMed ID: 24128122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanosystems in nose-to-brain drug delivery: A review of non-clinical brain targeting studies.
    Pires PC; Santos AO
    J Control Release; 2018 Jan; 270():89-100. PubMed ID: 29199063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation, characterization, and optimization of asenapine maleate mucoadhesive nanoemulsion using Box-Behnken design: In vitro and in vivo studies for brain targeting.
    Kumbhar SA; Kokare CR; Shrivastava B; Gorain B; Choudhury H
    Int J Pharm; 2020 Aug; 586():119499. PubMed ID: 32505580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of RPMI 2650 as a cell model to evaluate solid formulations for intranasal delivery of drugs.
    Gonçalves VSS; Matias AA; Poejo J; Serra AT; Duarte CMM
    Int J Pharm; 2016 Dec; 515(1-2):1-10. PubMed ID: 27702697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent patents review on intranasal administration for CNS drug delivery.
    Jogani V; Jinturkar K; Vyas T; Misra A
    Recent Pat Drug Deliv Formul; 2008; 2(1):25-40. PubMed ID: 19075895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intranasal Nose-to-Brain Drug Delivery via the Olfactory Region in Mice: Two In-Depth Protocols for Region-Specific Intranasal Application of Antibodies and for Expression Analysis of Fc Receptors via In Situ Hybridization in the Nasal Mucosa.
    Herzog H; Glöckler S; Flamm J; Ladel S; Maigler F; Pitzer C; Schindowski K
    Methods Mol Biol; 2024; 2754():387-410. PubMed ID: 38512678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative analysis of drug delivery to the brain via nasal route.
    Kozlovskaya L; Abou-Kaoud M; Stepensky D
    J Control Release; 2014 Sep; 189():133-40. PubMed ID: 24997277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.